Lotus Pharmaceuticals, Inc. - FORM 10-K - EX-23 - CONSENT OF FRIEDMAN LLP - March 28, 2011

Attached files

file filename
10-K - FORM 10-K FOR 12-31-2010 - Lotus Pharmaceuticals, Inc.form_10-k.htm
EX-31 - RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CEO - Lotus Pharmaceuticals, Inc.ex_31-1.htm
EX-32 - SECTION 1350 CERTIFICATION OF CEO - Lotus Pharmaceuticals, Inc.ex_32-1.htm
EX-31 - RULE 13A-14(A)/ 15D-14(A) CERTIFICATION OF CFO - Lotus Pharmaceuticals, Inc.ex_31-2.htm
EX-14 - CODE OF BUSINESS CONDUCT AND ETHICS - Lotus Pharmaceuticals, Inc.ex_14-1.htm
EX-32 - SECTION 1350 CERTIFICATION OF CFO - Lotus Pharmaceuticals, Inc.ex_32-2.htm

Exhibit 23.1




CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



We consent to the incorporation by reference in Registration Statement on Form S-8 (SEC File No. 333-169229) of Lotus Pharmaceuticals, Inc. of our report dated March 28, 2011 relating to our audits of the consolidated financial statements which appear in this Annual Report on Form 10-K of Lotus Pharmaceuticals, Inc. for the years ended December 31, 2010 and 2009.



/s/ Friedman LLP


New York, New York

March 28, 2011


Lotus Pharmaceuticals, Inc. Reports

Also read